The relative bioavailability of 2 prototype fixed‐dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|5|2|131-140

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.5, Iss.2, 2016-03, pp. : 131-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension

By Deeks Emma D.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 411-418

Adis International

Access to resources Recommend Favorite

Amlodipine/Valsartan: Fixed-Dose Combination in Hypertension

By Plosker Greg L.   Robinson Dean M.  

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 373-381

Adis International

Access to resources Recommend Favorite

Bioequivalence of fixed‐dose combinations of dapagliflozin and metformin with single‐component tablets in healthy subjects and the effect of food on bioavailability

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 118-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension

By Deeks Emma D.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 209-220

Adis International

Access to resources Recommend Favorite

Amlodipine/valsartan fixed-dose combination: a guide to its use in hypertension

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 8, 2008-08 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite